first glp-1 approval Navigating the -tides: Medication-Assisted Weight Loss on the Forefront World Pharma Today | 🎉

CT scans and DEXA scans during the early months frequently show dramatic visceral fat reduction even when the midsection still looks largely unchanged from the outside

But what we are seeing is food makers develop new product ranges targeting people taking weight-loss drugs

Clinical evidence from randomized trials and associated meta-analysis suggest thyroid cancer as a rare event making effect estimates imprecise but without conclusive and consistent evidence of increase risk in those receiving GLP-1 RA

Mounjaro helps manage type 2 diabetes, while Zepbound aids in chronic weight management, suitable for adults with obesity or overweight adults having weight-related conditions like high blood pressure or type 2 diabetes

Holly Wyatt, an adjoint associate professor in medicine at the University of Colorado Anschutz

Among individuals with obesity and type 2 diabetes, both medications were associated with lower hazards of anxiety disorders, broadly defined cognitive deficits, mood disorders, and depression